Why M&A Is a Driver of Rare Disease Innovation

Why M&A Is a Driver of Rare Disease Innovation

A new BioSpace article highlights an urgent challenge: maintaining America’s leadership in developing rare disease treatments amid increasing global competition. Meeting that challenge will require policies that support the full life sciences innovation ecosystem –...